Radioisotope manufacturer International Isotopes saw its revenue decrease 10% and its net loss increase in 2013.
Revenues declined to $6.8 million in 2013, compared with $7.6 million in 2012. The company also posted a net loss of $2.5 million last year, compared with a net loss of $2.2 million in 2012.
Sales in the company's Nuclear Medicine Standards business segment, which accounted for approximately 47% of the company's total revenue in 2013, decreased by 22% compared to 2012.
Commenting on the results, President and CEO Steve Laflin said the company made significant progress during the past year in addressing sales and production issues and has set the stage for improved revenue and performance in 2014.
